Simplifying Global Compliance
Medical Product Advertising & Promotion - Webinar Recording/Transcript
| Quantity Discounts | 1 - 2 $287.00 | 3 - 4 $258.00 | 5 - 6 $244.00 | 7 - 9 $230.00 | 10 - 9999 $215.00 |
Medical Product Advertising & Promotion: Social Media Do's and Don'ts
Social media is a two-edged sword — a boon for getting your message out, a magnet for warning letters should you run afoul of the FDA.
And other agencies are watching your social media behavior too — the FTC and the CPSC, to name two. Time to consult a lawyer? Or simply ...
Two of Washington’s top lawyers specializing in the intersection of social media and federal regulation discuss:
- Common social media mistakes that trigger warning letters
- How to deal with misleading, untruthful and/or biased posts
- FDA enforcement activities to date
- Use of social media for adverse event reporting and product improvement
- Likely FDA moves that could affect your use of social media
- And much more!
Your presenters, Naomi J.L. Halpern Esq. and Georgia C. Ravitz Esq., are experts at the Washington headquarters of Arent Fox LLP. Spend 90 minutes picking their brains — without paying one cent extra in billable hours.
FDA guidances set the social media rules, but also offer useful help — managing your social media presence, for public disclosures for sharing marketing and off-label information, and dealing with damaging information posted on social media.
Social media will only grow more central to your marketing and communications. But it’s a legal minefield too, best navigated with the help of expert lawyers. That’s reason enough to take part in this timely presentation.
This session is appropriate for organizations subject to FDA, FTC and CPSC regulation, specifically individuals holding job titles including:
- Regulatory and compliance
- Legal affairs/general counsel
- Outside counsel
- Marketing and sales
- Advertising execs, in-house and agency
- Medical affairs
Meet Your Presenters
Naomi J.L. Halpern Esq. and Georgia C. Ravitz Esq., Arent Fox LLP. Ms. Halpern is counsel specializing in FDA, FTC and CPSC regulation of advertising and promotion of drugs, biologics, supplements, foods, cosmetics and consumer products. Ms. Ravitz is a senior partner specializing in FDA, agriculture, advertising and consumer product safety regulation, working with FDA-regulated firms cited for false advertising unfair sales and marketing practices. She also deals with matters of alleged false and misleading advertising by competitors.
